RGA · Reinsurance Group Of America Inc
$239.00
+0.09 (+0.04%)
At close · Jul 27
Market Cap
$15.65B
Shares
65.51M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$23.7B
+7.2%
FY2025
Net Income
$1.18B
+64.9%
FY2025
Diluted EPS
$17.69
+64.9%
FY2025
Operating Cash Flow
$4.09B
-56.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $24.93B | $23.7B | $22.11B | $18.57B | $16.23B | $16.67B | $14.6B | $14.3B | $12.88B | $12.52B | $11.52B | $10.42B | $10.9B | $10.32B | $9.84B | $8.83B | $8.26B | $7.07B | $5.68B | |
| $17.81B | $17.23B | $17.84B | $15.09B | $13.08B | $12.51B | $11.69B | $11.3B | $10.54B | $9.84B | $9.25B | $8.57B | $8.67B | $8.25B | $7.91B | $7.34B | $6.66B | $5.73B | $5.35B | |
| — | $43M | $46M | $41M | $38M | $43M | $49M | $49M | $45M | $53M | $26.85M | $31.1M | $15.31M | $1.09B | $1.19B | $895.81M | $1.13B | $1.04B | — | |
| $385M | $366M | $304M | $257M | $191M | $139M | $170M | $173M | $147M | $146M | $137.62M | $142.86M | $96.7M | $124.31M | $105.35M | $102.64M | $91M | $69.94M | $76.16M | |
| -$336M | -$245M | -$745M | -$481M | -$539M | $567M | -$33M | $91M | -$170M | $168M | $94.2M | -$164.75M | $186.19M | $63.99M | $254.14M | -$36.06M | $212.03M | $34.15M | -$647.21M | |
| $1.61B | $1.54B | $980M | $1.16B | $718M | $1.39B | $553M | $1.13B | $846M | $1.14B | $1.04B | $744.8M | $1.01B | $635.25M | $919.22M | $763.57M | $806.18M | $540.56M | — | |
| $380M | $351M | $256M | $251M | $197M | $215M | $138M | $262M | $130M | -$679M | $342.5M | $242.63M | $324.49M | $216.42M | $287.33M | $217.53M | $270.44M | $167.56M | $92.58M | |
| $1.23B | $1.18B | $717M | $902M | $517M | $1.17B | $415M | $870M | $716M | $1.82B | $701.44M | $502.17M | $684.05M | $418.84M | $631.89M | $546.05M | $535.74M | $373M | $176.8M | |
| — | 4.99% | 3.24% | 4.86% | 3.19% | 7.02% | 2.84% | 6.08% | 5.56% | 14.56% | 6.09% | 4.82% | 6.27% | 4.06% | 6.42% | 6.18% | 6.48% | 5.28% | 3.11% | |
| $6M | $7M | $7M | $7M | $4M | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| $2.3B | $3.02B | $1.94B | $2.4B | -$854M | $1.58B | $2.64B | $3.37B | -$708M | $2.59B | $1.13B | -$446.68M | $1.34B | -$684.46M | $1.12B | $1.27B | $1.14B | $1.21B | -$898.28M | |
| USD/shares | — | $17.94 | $10.90 | $13.60 | $7.73 | $17.26 | $6.35 | $13.88 | $11.25 | $28.28 | $10.91 | $7.55 | $9.88 | $5.82 | $8.57 | $7.42 | $7.32 | $5.12 | — |
| USD/shares | — | $17.69 | $10.73 | $13.44 | $7.64 | $17.13 | $6.31 | $13.62 | $11.00 | $27.71 | $10.79 | $7.46 | $9.78 | $5.78 | $8.52 | $7.37 | $7.17 | $5.09 | — |
| shares | — | 65.9M | 65.8M | 66.3M | 66.9M | 67.8M | 65.4M | 62.7M | 63.7M | 64.43M | 64.27M | 66.55M | 69.25M | 71.92M | 73.74M | 73.59M | 73.16M | 72.79M | — |
| shares | — | 66.8M | 66.9M | 67.1M | 67.7M | 68.3M | 65.8M | 63.9M | 65.1M | 65.75M | 64.99M | 67.29M | 69.96M | 72.46M | 74.15M | 74.11M | 74.69M | 73.33M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $2.24B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
12.94×
Peer median 6.39×
Peer medians compare against the 5 similar-size Insurance - Reinsurance companies (of 8 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|
| Corporate And Other | $335,000,000 | $230,000,000 | $789,000,000 | $245,000,000 | $257,000,000 | $84,000,000 | $156,000,000 |
| Canada | — | — | — | — | $1,385,000,000 | $1,273,000,000 | $1,152,000,000 |
| Americas | — | — | — | — | $7,779,000,000 | $7,203,000,000 | $7,251,000,000 |
| Asia Pacific | — | — | — | — | $2,909,000,000 | $2,471,000,000 | $2,284,000,000 |
| EMEA | — | — | — | — | $1,970,000,000 | $1,845,000,000 | $1,673,000,000 |
By Geography (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Americas | $10,447,000,000 | $8,611,000,000 | $8,641,000,000 | $7,780,000,000 | $7,779,000,000 | $7,203,000,000 |
| Asia Pacific | $3,700,000,000 | $3,357,000,000 | $3,245,000,000 | $3,115,000,000 | $2,909,000,000 | $2,471,000,000 |
| EMEA | $2,505,000,000 | $2,444,000,000 | $2,429,000,000 | $2,104,000,000 | $1,970,000,000 | $1,845,000,000 |
| Canada | $1,580,000,000 | $1,585,000,000 | $1,563,000,000 | $1,352,000,000 | $1,385,000,000 | $1,273,000,000 |
By Product & Service (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|
| Life Insurance Segment | $14,213,000,000 | $13,740,000,000 | $13,253,000,000 | $12,259,000,000 | $23,974,000,000 | $22,864,000,000 | $10,775,000,000 |
| Other Insurance Product Line | $4,019,000,000 | $2,257,000,000 | $2,625,000,000 | $2,092,000,000 | $4,112,000,000 | $2,720,000,000 | $1,585,000,000 |
Key facts
CIK
898174
CUSIP
759351604
13F (30d)
134 filings
132 filers
Visit website
Investor relations